Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
CRI Worldwide - Kirkbride Center
mi
from
Philadelphia, PA
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
CRI Worldwide - Kirkbride Center
mi
from
Philadelphia, PA
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Pillar Clinical Research, LLC
mi
from
Dallas, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
Pillar Clinical Research, LLC
mi
from
Dallas, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Wharton Research Center
mi
from
Wharton, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
Wharton Research Center
mi
from
Wharton, TX
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
University Of Utah Hospital
mi
from
Salt Lake City, UT
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
University Of Utah Hospital
mi
from
Salt Lake City, UT
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
LIfestyle Prosthetics & Orthotics
mi
from
North Andover, MA
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Status: Archived
Updated: 1/1/1970
LIfestyle Prosthetics & Orthotics
mi
from
North Andover, MA
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Boston Med Center
mi
from
Boston, MA
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Dartmouth Medical School
mi
from
Lebanon, NH
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Updated: 1/1/1970
Dartmouth Medical School
mi
from
Lebanon, NH
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Varenicline for Alcohol Dependence
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
A Prospective Trial of Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic (CAE-L) in Individuals With Schizophrenia or Schizoaffective Disorder at Risk for Treatment Non-adherence and for Homelessness
Status: Archived
Case Western Reserve Univ
mi
from
Cleveland, OH
Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
A Prospective Trial of Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic (CAE-L) in Individuals With Schizophrenia or Schizoaffective Disorder at Risk for Treatment Non-adherence and for Homelessness
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
The Effect of Guanfacine Extended-release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
The Effect of Guanfacine Extended-release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Status: Archived
Children`s Hospital of Philadelphia : University of Philadelphia
mi
from
Philadelphia, PA
The Effect of Guanfacine Extended-release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
The Effect of Guanfacine Extended-release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Status: Archived
Updated: 1/1/1970
Children`s Hospital of Philadelphia : University of Philadelphia
mi
from
Philadelphia, PA
Dynamic Assessment and Referral System - Evaluation
The Dynamic Assessment and Referral System for Substance Abuse: Evaluation
Status: Archived
Umass Memorial Medical Center
mi
from
Worcester, MA
Dynamic Assessment and Referral System - Evaluation
The Dynamic Assessment and Referral System for Substance Abuse: Evaluation
Status: Archived
Updated: 1/1/1970
Umass Memorial Medical Center
mi
from
Worcester, MA
Pilot Study of Depot NTX in Homeless Veterans
Pilot Study of Depot Naltrexone in Alcohol-Dependent, Homeless Veterans
Status: Archived
Providence Western Washington Oncology
mi
from
Lacey, WA
Pilot Study of Depot NTX in Homeless Veterans
Pilot Study of Depot Naltrexone in Alcohol-Dependent, Homeless Veterans
Status: Archived
Updated: 1/1/1970
Providence Western Washington Oncology
mi
from
Lacey, WA
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Status: Archived
Children`s Hospital of Philadelphia : University of Philadelphia
mi
from
Philadelphia, PA
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Status: Archived
Updated: 1/1/1970
Children`s Hospital of Philadelphia : University of Philadelphia
mi
from
Philadelphia, PA
Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth
Effect of D-cycloserine on Treatment of PTSD in Youth
Status: Archived
Tulane University Health Sciences Center, 1440 Canal St.
mi
from
New Orleans, LA
Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth
Effect of D-cycloserine on Treatment of PTSD in Youth
Status: Archived
Updated: 1/1/1970
Tulane University Health Sciences Center, 1440 Canal St.
mi
from
New Orleans, LA
D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents
D-cycloserine Adjunctive Treatment for PTSD in Adolescents
Status: Archived
Tulane University Health Sciences Center, 1440 Canal St.
mi
from
New Orleans, LA
D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents
D-cycloserine Adjunctive Treatment for PTSD in Adolescents
Status: Archived
Updated: 1/1/1970
Tulane University Health Sciences Center, 1440 Canal St.
mi
from
New Orleans, LA
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Status: Archived
Recovery Centers of King County
mi
from
Seattle, WA
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Status: Archived
Updated: 1/1/1970
Recovery Centers of King County
mi
from
Seattle, WA
Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer
Impact of Acceptance and Commitment Therapy on Salivary Cortisol in Breast Cancer
Status: Archived
San Jose State University
mi
from
San Jose, CA
Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer
Impact of Acceptance and Commitment Therapy on Salivary Cortisol in Breast Cancer
Status: Archived
Updated: 1/1/1970
San Jose State University
mi
from
San Jose, CA
Protective Behavioral Strategies and Brief Alcohol Interventions
Protective Behavioral Strategies and Brief Alcohol Interventions
Status: Archived
University of Missouri
mi
from
Columbia, MO
Protective Behavioral Strategies and Brief Alcohol Interventions
Protective Behavioral Strategies and Brief Alcohol Interventions
Status: Archived
Updated: 1/1/1970
University of Missouri
mi
from
Columbia, MO
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Youth Reporting Center (Youth Services Center)
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
Youth Reporting Center (Youth Services Center)
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Sandia Preparatory School
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
Sandia Preparatory School
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Albuquerque Academy
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
Albuquerque Academy
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention (CBT/ERP) in Adults and Adolescents With Obsessive Compulsive Disorder
Open-Label Exploratory Investigation of D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention for Adults and Adolescents Diagnosed With Obsessive Compulsive Disorder - A Feasibility Study
Status: Archived
New York State Psychiatric Insitute
mi
from
New York, NY
D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention (CBT/ERP) in Adults and Adolescents With Obsessive Compulsive Disorder
Open-Label Exploratory Investigation of D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention for Adults and Adolescents Diagnosed With Obsessive Compulsive Disorder - A Feasibility Study
Status: Archived
Updated: 1/1/1970
New York State Psychiatric Insitute
mi
from
New York, NY
Stress, Hormones, and Eating
Novel Interventions to Reduce Stress Induced Non-homeostatic Eating
Status: Archived
University California San Francisco
mi
from
San Francisco, CA
Stress, Hormones, and Eating
Novel Interventions to Reduce Stress Induced Non-homeostatic Eating
Status: Archived
Updated: 1/1/1970
University California San Francisco
mi
from
San Francisco, CA
Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD)
Organizational Skills Interventions for Children With ADHD
Status: Archived
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD)
Organizational Skills Interventions for Children With ADHD
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Cognitive-Behavior Therapy for Young Adults With Bipolar Disorder
Reducing High-Risk Behaviors Among Bipolar Patients Transitioning to Adulthood
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Cognitive-Behavior Therapy for Young Adults With Bipolar Disorder
Reducing High-Risk Behaviors Among Bipolar Patients Transitioning to Adulthood
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
CBT for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
Status: Archived
Univeristy of California at Los Angeles
mi
from
Los Angeles, CA
Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
CBT for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
Status: Archived
Updated: 1/1/1970
Univeristy of California at Los Angeles
mi
from
Los Angeles, CA
Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
CBT for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
Status: Archived
Univeristy of South Florida
mi
from
Tampa, FL
Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
CBT for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
Status: Archived
Updated: 1/1/1970
Univeristy of South Florida
mi
from
Tampa, FL
Sex Differences in Attentional Bias in Marijuana-dependent Individuals
Sex Differences in Attentional Bias and Cognitive Functioning in Response to Stress in Marijuana-dependent Individuals
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
Sex Differences in Attentional Bias in Marijuana-dependent Individuals
Sex Differences in Attentional Bias and Cognitive Functioning in Response to Stress in Marijuana-dependent Individuals
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement
Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement
Status: Archived
University of Connecticut Health Center
mi
from
Farmington, CT
Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement
Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement
Status: Archived
Updated: 1/1/1970
University of Connecticut Health Center
mi
from
Farmington, CT
Multidimensional Measurement of Psychopharmacological Treatment Response
Actigraphic, Observational, Psychometric and Biological Measurement of Psychopharmacological Treatment Response
Status: Archived
Child Psychopharmacology Institute
mi
from
Fargo, ND
Multidimensional Measurement of Psychopharmacological Treatment Response
Actigraphic, Observational, Psychometric and Biological Measurement of Psychopharmacological Treatment Response
Status: Archived
Updated: 1/1/1970
Child Psychopharmacology Institute
mi
from
Fargo, ND
Sexual Health on Antidepressants Through Physical Exercise
Sexual Health on Antidepressants Through Physical Exercise
Status: Archived
University of Texas at Austin
mi
from
Austin, TX
Sexual Health on Antidepressants Through Physical Exercise
Sexual Health on Antidepressants Through Physical Exercise
Status: Archived
Updated: 1/1/1970
University of Texas at Austin
mi
from
Austin, TX
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Intermountain Medical Center
mi
from
Murray, UT
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Updated: 1/1/1970
Intermountain Medical Center
mi
from
Murray, UT
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Discovery Research
mi
from
West Bend, WI
Methadone Monitoring for Insights Into Adverse Events
Methadone Monitoring for Insights Into Adverse Events
Status: Archived
Updated: 1/1/1970
Discovery Research
mi
from
West Bend, WI
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Denver, CO
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Denver, CO
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Celebration, FL
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Atlanta, GA
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Atlanta, GA
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Centralia, IL
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Centralia, IL
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Kansas City, KA
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Kansas City, KA
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Jackson, MS
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jackson, MS
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
St Louis, MO
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
St Louis, MO
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Albany, NY
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Philadelphia, PA
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA